IONTAS and IGEM Collaborate to Find Novel IgE Antibodies for Cancer Treatment

IONTAS and IGEM Collaborate to Find Novel IgE Antibodies for Cancer Treatment
The development of novel IgE antibodies targeting solid tumors will receive a boost following a new collaboration between IONTAS and IGEM Therapeutics. IGEM is an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer. The collaboration will add to IGEM’s pipeline of therapies and expand upon IGEM-F, an IgE antibody targeting ovarian and other cancers

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *